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Abstract 
Infection is the major reason for guided tissue regeneration/guided bone regeneration (GTR/GBR) membrane 
failure in clinical application. In this work, we developed GTR/GBR membranes with localized drug delivery 
function to prevent infection by electrospinning of poly(ε-caprolactone) (PCL) and gelatin blended with 
metronidazole (MNA). Acetic acid (HAc) was introduced to improve the miscibility of PCL and gelatin to fabricate 
homogeneous hybrid nanofiber membranes. The effects of the addition of HAc and the MNA content (0, 1, 5, 10, 
20, 30, and 40 wt.% of polymer) on the properties of the membranes were investigated. The membranes showed 
good mechanical properties, appropriate biodegradation rate and barrier function. The controlled and sustained 
release of MNA from the membranes significantly prevented the colonization of anaerobic bacteria. Cells could 
adhere to and proliferate on the membranes without cytotoxicity until the MNA content reached 30%. 
Subcutaneous implantation in rabbits for 8 months demonstrated that MNA-loaded membranes evoked a less 
severe inflammatory response depending on the dose of MNA than bare membranes. The biodegradation time of 
the membranes was appropriate for tissue regeneration. These results indicated the potential for using MNA-loaded 
PCL/gelatin electrospun membranes as anti-infective GTR/GBR membranes to optimize clinical application of 
GTR/GBR strategies. 
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Introduction 
Guided tissue regeneration/guided bone regeneration (GTR/GBR) technologies are a frequently used standard 
procedure for tissue and bone regeneration therapy [1]. The principle of GTR/GBR membranes is used not only to 
perform the barrier function by preventing the ingrowth of fibroblast cells into the tissue/bone defect site but also to 
improve the tissue/bone regeneration by supporting cells to attach and proliferate [2].Conventionally, GTR/GBR 
membranes require flexibility to adapt to and optimally cover a tissue defect, biocompatibility, and proper 
degradation profile to eliminate the need for membrane removal surgery [3]. 
Infection is currently considered as the major reason for GTR/GBR failure in clinical applications, constituting a 
significant healthcare burden [4]. Infection is caused by either bacterial colonization at the wound site or foreign 
body response resulting from the implant material [5].Antibacterial biomaterials are one of the greatest interests in 
the war against implant-related infections, representing the broadest group of anti-infective biomaterials [6]. Focal 
antibacterial drug-loaded biomaterials can deliver a desired drug dose directly to the infected site for an extended 
time period while minimizing systemic distribution of toxic drugs [7,8]. Infection associated with GTR/GBR 
implant is mainly caused by anaerobic bacteria [9,10]. Metronidazole (MNA), which has selective activity against 
anaerobic microorganisms including bacteria and protozoa [11], has been successfully used for the treatment of 
anaerobic bacterial infections for more than 45 years [12]. MNA-loaded poly(lactic-co-glycolic acid) membrane 
fabricated by solvent casting showed a significant improvement on the periodontal regeneration following GTR in 
dogs [13].Our purpose is to develop an anti-infective GTR/GBR membrane with sufficient localized MNA release. 
Electrospinning has gained widespread interest in tissue engineering and drug delivery because of its relative 
ease of use and adaptability [14]. The inherently high surface to volume ratio of electrospun polymer fibers can 
improve cell attachment, enhance drug loading, and realize sustained and controlled local drug delivery [15]. The 
drug release profile and the degradation rate of the electrospun membranes can be adjusted by regulating the 
electrospinning parameters [16]. Therefore, electrospinning was adopted to fabricate the antibacterial membranes in 
this study. 
Numerous natural and synthetic polymers have been investigated for the fabrication of GTR/GBR membranes. 
Collagen has excellent biocompatibility, but it collapses quickly during the degradation process [17]. Although 
poly(lactic acid)- and poly(lactic-co-glycolic acid)-based nanofiber membranes are also non-cytotoxic and 
biodegradable, the rapid releases of oligomers and acid by-products during degradation may cause significant 
inflammation reactions and foreign body response in vivo [18]. PCL is extensively studied for controlled drug 
delivery because of its compatibility with a wide range of drugs and good mechanical properties [19,20],but it often 
results in low cell adhesion and proliferation and the biodegradation rate of PCL is low. Gelatin, a natural 
biopolymer derived from partial hydrolysis of native collagen, has many integrin-binding sites for cell adhesion and 
differentiation [21]. PCL-gelatin hybrid material, a new biomaterial with good biocompatibility and improved 
mechanical, physical, and chemical properties [22], has been successfully used in various tissue engineering 
applications [23-25]. However, phase separation between PCL and gelatin adversely affect both the electrospinning 
process and the resultant fiber performance. Induction of acetic acid was reported to be effective in mediating the 
miscibility of PCL and gelatin and forming homogeneous nanofibers with improved performance [26]. 
On the basis of the aforementioned, MNA-loaded homogeneous PCL/gelatin electrospun nanofiber membranes 
were fabricated. The current study aimed to (i) develop MNA-loaded membranes as anti-infective GTR/GBR 
membranes and (ii) investigate their anti-bacterial and anti-infection properties by using a long term subcutaneous 
implantation model. For these purposes, GTR/GBR membranes were prepared by blending PCL, gelatin, and MNA 
by using an electrospinning technique. HAc was added to the electrospinning system to obtain homogeneous 
nanofibers. Our hypothesis was that (i) the electrospun membranes containing the use of HAc would show 
improved performance and (ii) the electrospun PCL/gelatin membrane loaded with MNA would reduce bacterial 
colonization and hence prevent infection in the defect site. The current work is expected to provide valuable 
information for the development of anti-infective GTR/GBR membranes. 
2. Materials and methods 
2.1. Materials 
PCL (Mn=70-90 kDa) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased 
from Sigma-Aldrich (St. Louis, USA) and used as received. Gelatin was purchased from Rousselot (France). 
Metronidazole (MNA) was purchased from Tokyo Chemical Industry Co., Ltd. (Japan). Dulbecco’s modified eagle 
medium (DMEM), fetal bovine serum (FBS), 0.05% Trypsin EDTA, and phosphate buffer saline (PBS, pH=7.4) 
were purchased from Gibco (USA). Methanol and trifluoroethanol (TFE) were purchased from Alfa-Aesar 
Chemical Inc. (USA). WST-8, polyformaldehyde and FITC–phalloidin were purchased from Beyotime Institute of 
Biotechnology (China). Other chemical reagents such as acetic acid, dichloromethane (DCM), and 
N-N’dimethylformamide (DMF) were purchased from Sinopharm Chemical Reagent Beijing Co., Ltd. (China) and 
used without further purification. MGC AnaeroPackTM Series was purchased from Mitsubishi Gas Chemical 
Company, Inc. (Japan). Brain heart infusion (BHI) broth and BHI agar were purchased form Oxoid (UK). L929 
fibroblast cell lines were kindly donated by Jishuitan Hospital. Human periodontal ligament fibroblasts (hPDLFs) 
and rat osteogenesis sample (ROS) cells were kindly donated by University of Sheffield (UK).  
2.2. Electrospinning nanofiber membranes 
A solution of PCL-gelatin was prepared by mixing 6 wt.% PCL/TFE and 6 wt.% gelatin/TFE in the mass ratio of 
50:50. A tiny amount (0.2 v/v% TFE) of HAc was dropped to the solution to obtain a transparent PCL-gelatin-HAc 
(PGH) solution. MNA in the range of 1-40 wt.% of the polymer used was added to the PGH solution. The solution 
was fed at a rate of 1 mL/h by a syringe pump to the needle tip of a 20 mL syringe. Optimized high voltage (8-12 
kV) was applied between the needle and the grounded collector, which was laid with aluminum foil at a rotating 
rate of 300 rpm. The needle was located at a distance of 20 cm from the ground collector. The membranes with 
MNA contents of 1%, 5%, 10%, 20%, 30%, and 40% were labeled as PGH1, PGH5, PGH10, PGH20, PGH30, and 
PGH40, respectively. To investigate the influence of incorporated gelatin and HAc on the properties of PGH-MNA 
membranes, membranes electrospun from PCL-MNA solution and PCL-gelatin-MNA solution were fabricated as 
control and labeled as Pc and PGc (c is the MNA content) , respectively. 
2.3. Characterization of PGH-MNA nanofiber membranes 
2.3.1. Morphology  
The morphology of the membranes was observed by scanning electron microscopy (SEM). The fiber diameter 
and pore size were measured by using the Image J software on SEM micrographs at 100 random locations. The 
thickness of a membrane was measured with a micrometer. The apparent density and porosity of the membrane 
were calculated by using equations (1) and (2), respectively [27]: 
 Apparent density (g 𝑐𝑚3⁄ ) =
Mass of membrane (g)
Membrane thickness (cm)× Membrane area (cm2)
 ,           (1)                    
  Porosity (%) = (1 −
 Apparent density (g 𝑐𝑚3⁄ )
Bulk density (g 𝑐𝑚3⁄ )
) × 100%                          (2) 
2.3.2. Molecular dynamics simulation, chemical, thermal, and mechanical analyses 
The interaction between PCL and MNA was investigated by molecular dynamics simulation (see S1). Fourier 
transform infrared (FT-IR) spectra were performed on a Bruker Tensor 27 spectrometer. The scan range was 4000 
cm−1 to 600 cm−1 with a resolution of 2 cm−1. Differential scanning calorimetry (DSC) measurements were 
performed with a Mettler-Toledo DSC instrument under nitrogen. The measurements were carried out at cooling 
and heating rate of 10 °C/min from –100 °C to 220 °C. X-ray diffraction (XRD) studies were conducted on a 
Rigaku D/max-Ultima III X-ray diffractometer equipped with Cu-K α source (40 kV, 40 mA) in the range of 5º to 
50º at a scan rate of 5º/min. 
The tensile properties of the membranes in both the dry state and the wet state were evaluated by using a BOSE 
ElectroForce 3200 test instrument with a 50-N load cell at a crosshead speed of 5 mm/min at the ambient 
temperature of 25 oC. All samples were cut into rectangles with dimensions of 25 mm×4 mm. Five samples in the 
dry state were tested for each membrane. Another five samples were soaked in deionized water for 1 h for wet state 
measurements. The thicknesses of the samples were measured with a micrometer accurate to 1 µm. 
2.3.3. Apparent water contact angle (WCA) measurements 
The static WCA of a membrane was measured by a SL200A type Contact Angle Analyzer (Solon (Shanghai) 
Technology Science Co., Ltd., China) at ambient temperature. Water droplets (3.0 μL) were dropped carefully onto 
the surface of the membrane. The average WCA value was obtained by measuring ten water droplets at randomly 
distributed positions. 
2.3.4. Drug encapsulation efficiency and drug release profile 
The drug encapsulation efficiency was determined as follows. A known mass of membrane was dissolved in 1 
mL of TFE, and the solution was added dropwise to 20 mL of methanol, in which the polymer was precipitated and 
MNA was dissolved. After centrifugation of the methanol solution, the liquid supernatant was detected by High 
Performance Liquid Chromatography (HPLC) at λmax =310 nm. The amount of MNA was obtained from the 
calibration curve of MNA. The encapsulation efficiency was calculated by the following equation: 
  Encapsulation efficiency % =
weight of drug in the sample (g)
theoretical  weight of drug loading in the sample (g)
 × 100%     (3). 
The drug release profile was determined by soaking the membrane in triplicate in PBS. The membrane was cut 
into circles 2 cm in diameter, accurately weighed, and incubated in 5 mL of PBS at 37 oC with mild shaking. At 
pre-determined time intervals, 1 mL of soaking solution was collected for HPLC detection to determine the amount 
of drug released. The remaining medium was removed and replaced with another 5 mL of fresh PBS to maintain 
the sink condition. The percentage of the drug released was calculated based on the initial weight of the drug 
incorporated in the electrospun membrane. 
2.3.5. In vitro biodegradation 
The membrane was cut into circular samples 2 cm in diameter, weighed, and soaked in 5 mL of PBS in 12-well 
plates at 37 oC. Samples were carefully removed from the wells at predetermined times, rinsed with Milli-Q water 
for three times, dried at 50 oC until the weight underwent no further changes, and then weighed. The sample 
weights were plotted against time to obtain the degradation profile of the membrane. The morphology and tensile 
properties of the membrane during degradation were measured by SEM and tensile testing, respectively.  
2.4. Barrier function, antibacterial activity, and biocompatibility 
2.4.1. Barrier function to fibroblast cells  
The in vitro barrier function of the membranes to L929 cells as model cells was evaluated by an elegant method 
we designed (schematic diagram as shown in S2). Each membrane was cut into a circle 2.5 cm in diameter, 
sterilized, fixed on a CellCrownTM (Sigma, USA), and put into a 24-well plate without touching the bottom of the 
well. L929 cells were resuspended in DMEM supplemented with 10% (v/v) FBS at a density of 4.0×104 cells/mL. 
Then 1 mL of culture medium without cells was added to the well from the outside of the CellCrownTM, and 900 μL 
of culture medium plus 100 μL of cell resuspension was added onto the sample. After incubated at 37 oC under a 5% 
CO2 atmosphere for 1 day, 3 days, 5 days, and 7 days, the CellCrownTM was taken out, and the bottom of the 
24-well plate was observed under an inverted phase contrast microscope (Olympus IX50-S8F2) to determine 
whether the cells got through the membrane to the bottom of the well or the culture medium. The other side of the 
membrane, which had no contact with the cells, was observed under a scanning electron microscope to find out 
whether the cells penetrated the membrane. The barrier function of the membranes after 1 month of degradation in 
PBS was also evaluated as above. 
2.4.2. In vitro antibacterial activity 
The antibacterial activity of the membranes against the typical anaerobic bacterium Fusobacterium nucleatum 
(ATCC 25586, Chinese General Microbiological Culture Collection Center), which is commonly found in the oral 
cavity in an infection [28], was determined by the modified Kirby–Bauer method [29] under anaerobic conditions 
[30]. Anaerobic environment was created by using MGC AnaeroPackTM-Anaero Series (Anaero-2.5 L is a 
disposable oxygen-absorbing and carbon dioxide generating agent for use in anaerobic jars, which has been widely 
used in laboratories to create anaerobic environment). The bacterial strain was inoculated onto BHI agar and 
anaerobically incubated at 37 °C for 24 h. After incubation, isolated bacterial colonies of the stock culture were 
suspended in sterile BHI broth until the turbidity was compatible with 0.5 Mac Farland. A 100 μL Fusobacterium 
nucleatum suspension was spreaded onto a BHI agar plate. Samples (1.0 cm×1.0 cm) of a membrane in triplicate 
were pasted onto the agar plate and incubated anaerobically for different times at 37 oC. All the samples were 
sterilized for 3 h under UV before they were pasted. The bacterial growth on the plate was visualized directly, after 
anaerobic incubation of the plates at 37 °C for 48 h, the diameter of the inhibition zone was measured. 
2.4.3. Cytotoxicity and proliferation of cells on the membranes 
The cytotoxicity of the membranes to L929 fibroblast cells, hPDLFs, and ROS cells was evaluated (see S3). The 
viabilities of L929 cells proliferated on the membranes were assessed by using CCK-8 assay referred to the 
manufacturer’s protocol. The membrane was cut into circles 2.5 cm in diameter and sterilized, then fixed in the 
well of a 24-well plate by Cell-CrownTM. L929 cells were resuspended in DMEM supplemented with 10% FBS and 
antibiotics (100 μg/mL penicillin and 100 mg/mL streptomycin) at a density of 4.0×104 cells/mL. Cell culture 
medium (800 μL) and cell resuspension (100 μL) were plated onto the sample carefully. Cell resuspensions added 
into wells with no samples were regarded as control. Plates were incubated at 37 oC under 5% CO2 atmosphere. 
The medium was changed every two days. At days 1, 3, 5, and 7 of culture, the sample was washed with PBS for 
three times to remove the cells that did not attach to the membrane, and 100 μL of WST-8 (final dilution: 1:10), 
which can react with dehydrogenase in mitochondria to form a water soluble formazan, was added onto the sample 
to test the live cells. Then 100 μL of supernatants was transferred into a 96-well plate for optical density (O.D.) 
measurements at 450 nm. The cell-cultured membrane was afterwards washed with PBS for three times, fixed with 
3% glutaraldehyde at 4 oC for 2 h, soaked in 0.18 M sucrose solutions at 4 oC for 2 h, dehydrated through a series 
of graded ethanol solutions, and lyophilized overnight. The morphologies of the cells on the membranes were 
observed by using SEM.  
The morphologies of the cells were also observed using laser scanning confocal microscope (CLSM, Olympus, 
FV1000-IX81). After incubated for 3 days and 7 days, the cell-cultured samples were washed twice with PBS, 
fixed with 4% polyformaldehyde for 10 min, and then stained with FITC–phalloidin solution (5 μg/mL) for 1 h. 
The samples were washed three times with PBS and visualized with CLSM. The CLSM images were obtained by 
focusing on the surface of the membranes as z-position. 
The proliferation of hPDLFs and ROS cells on the membranes were also tested by PrestoBlue assay. The 
membranes cut into circles 2.5 cm in diameter were disinfected in 100% isopropanol for 20 minutes and then rinsed 
in PBS for three times. The circular samples were fixed with Cell-CrownTM on a 24-well plate. After the addition of 
800 μL of culture medium on the membrane per well, hPDLFs and ROS cells separately resuspended in 100 μL of 
culture medium at a density of 5×105 cells/mL were added gently on each membrane. After 2 days of incubation, 
100 μL of PrestoBlueTM was pipetted per well. At 1 hour incubation, 200 μL of supernatants was transferred into a 
96-well plate, and fluorescence intensity was measured using a fluorescence reader (TECAN Spectrophometer) at 
an excitation wavelength of 570 nm and emission wavelength of 600 nm. 
2.5. In vivo biocompatibility and biodegradation  
To evaluate the influence of MNA content on the in vivo anti-infection property, biocompatibility, and 
biodegradability of the membranes, PGH5, PGH10, and PGH30 were subcutaneous implanted while P0 and P30 
were used as control. 
Forty healthy adult male New Zealand white rabbits (2.5–3.0 kg each) were used as experimental animals. The 
protocol for animal experiments was approved by the Animal Ethical Committee of the Laboratory of Bone Tissue 
Engineering of Beijing Research Institute of Traumatology and Orthopedics, and national guidelines for the care 
and use of laboratory animals were applied. Samples (1.5 cm×1.5 cm) were sterilized by γ-irradiation. The animals 
were anesthetized with isoflurane, and their backs were shaved and sterilized with alcohol and iodine scrubs. Three 
paravertebral incisions (2 cm each) per rabbit were made approximately 1 cm lateral to the vertebral column to 
expose the dorsal subcutis. Subcutaneous pockets were created by blunt dissection. Each individual pocket held one 
membrane, and the incisions were closed with surgical sutures. All surgeries were carried out in an aseptic field by 
using aseptic technique. The long term biocompatibility of the samples was evaluated for 8 months of implantation 
[25,26]. After post-surgery 1 week, 3 weeks, 5 weeks, 7 weeks, 8 weeks, 3 months, 6 months, and 8 months, the 
implants were harvested and stained with hematoxylin and eosin (H&E) for morphological evaluation as usual 
procedure. The infiltration of inflammatory cells and the thickness of the inflammatory fibrous capsule formed 
around a cross section of the implant were assessed to evaluate the extent of inflammation, foreign body reaction 
and biocompatibility of each sample. Explanted membranes were observed by SEM. 
2.6. Statistical analysis 
Statistical comparisons for significance were conducted using Students’ t-test with a 95% confidence level. Each 
data point was expressed as mean ± standard deviation. 
3. Results 
3.1. Characterization of electrospun membranes 
3.1.1. Influence of HAc on morphology of PCL-gelatin electrospun membranes 
Because of the sol-gel transition of gelatin and the immiscibility of PCL and gelatin, the mixed solution of 
PCL/TFE and gelatin/TFE becomes opaque and gradually separates into different layers after being mixed for 3 
hours. After a tiny amount of HAc was added to the mixed solution, the pH of the solution is away from the 
isoelectric point of gelatin, restricting the sol-gel transition of gelatin. Besides, the gelatin molecules, which are 
positively charged because of the protonation of amino groups, become mutually exclusive and entangle with the 
PCL chains [18].A miscible and transparent solution was formed and no sign of two liquid layers was observed, as 
shown in Fig. S3. Micro- and nanofibers coexist in PG0 while smooth and uniform nanofibers are exclusively 
formed in PGH0. The hierarchically sized fibers of PG0 will influence the overall homogeneity of the membranes.  
3.1.2. Morphology of electrospun membranes 
The SEM micrographs of the PGH-MNA membranes (Fig. 1) show a randomly interconnected structure with no 
beads formed and uniform distribution of nanofibers. As shown in Table 1, the diameters of the nanofibers are 
influenced by the MNA content, the nanofibers of PGH10 being the thinnest. The much smaller pore sizes of the 
membranes than the size of fibroblasts are beneficial to preventing the ingrowth of fibroblasts into the tissue defects. 
The porosities of the membranes are all in the range of 60%-80%, ensuring sufficient gas and nutrient exchanges. 
Thus, we have successfully fabricated drug-loaded homogeneous hybrid nanofiber membranes. 
3.1.3. Chemical, thermal, and mechanical properties and hydrophilicity of the nanofiber membranes 
The compatibility and interaction between the polymer matrix and drug influence the encapsulation and release 
of drugs in the nanofibers [18].Molecular dynamics simulation results showed that MNA can form hydrogen bonds 
(HBs) with PCL (S4) while the MNA molecules, which are hydrophilic, also have interaction with gelatin. 
According to the ATR-FTIR spectra of the electrospun membranes (Fig. 2A), the characteristic peaks of gelatin 
appear at approximately 1650 cm-1 (amide I) and 1540 cm-1 (amide II). The PCL-related stretching modes are 
represented by the peaks at 2943 cm-1 (asymmetric CH2 stretching), 2866 cm-1 (symmetric CH2 stretching), 1721 
cm-1 (C=O stretching), 1294 cm-1 (C-O and C-C stretching), and 1240 cm-1 (asymmetric C-O-C stretching) [31]. 
The MNA-related stretching modes represented by the peaks at 3414 cm-1 and 3220 cm-1 (O-H stretching), 3097 
cm-1 (=CH stretching), and 1550 cm-1 (-NO2 antisymmetric stretching), are no different from those of pure MNA 
crystals. The relative intensities of these peaks increase with increasing MNA content. Besides, the width of the 
characteristic hydroxyl peaks of MNA at 3414 cm-1 and 3220 cm-1 increase compared with that of pure MNA, 
because of the hydrogen interaction between MNA and the polymer matrix. Other interactions include the hydrogen 
interaction between PCL and gelatin [31]. By adding HAc, the chain entanglement and hydrogen interaction 
between PCL and gelatin increase, and MNA disperses more homogenously in the electrospinning solution. The 
electrospinning process does not adversely affect the molecular structure of MNA, especially the antibacterial -NO2 
group. 
The DSC thermograms of the membranes are shown in Fig. 2B. At MNA contents lower than 20%, the absence 
of the MNA melting peak indicates that MNA is dispersed on the molecular level. At MNA contents of 20%, 30%, 
and 40%, the melting peak of MNA appears, indicating the formation of MNA crystals. The endothermic enthalpy 
of melting of a perfect PCL crystal is 139 J/g [32], and the endothermic melting enthalpies of PCL in P0, PG0, and 
PGH0 are 70.4 J/g, 68.1 J/g, and 66.0 J/g, respectively. From these enthalpy data, the degrees of crystallinity of 
PCL in P0, PG0, and PGH0 are calculated to be 50.6%, 49.0%, and 47.5%, respectively. The crystallinity of PCL 
decreases with the incorporation of gelatin and HAc. With the incorporation of gelatin, the gelatin molecular chains 
entangle with PCL molecular chains. With the further addition of HAc, the miscibility and interaction between 
gelatin and PCL are improved, resulting in more chain entanglements, which restrict the chain mobility and 
crystallization of PCL. The lower crystallinity of PCL indicates better miscibility of PCL and gelatin hybrid 
nanofibers. For drug-loaded biomedical materials, the drug should be stable in the polymer matrix during the 
storage period. The DSC thermograms of the membranes after storage for 1 month, 3 months, and 6 months (data 
not shown) showed that the thermal properties of the membranes did not change with storage time.  
In the XRD pattern (Fig. 2C), the two diffraction peaks located at 21.4o and 23.8o are assigned to semi-crystalline 
PCL. The absence of a diffraction peak in the XRD pattern of gelatin indicates that gelatin is amorphous. As the 
MNA content increases, the two peaks of PCL shift to slightly higher angles, indicating that the length of PCL 
crystal stacks decreases, probably because the MNA molecules and gelatin molecular chains among the PCL 
molecular chains restrain the formation of PCL crystal stacks. The orientation of the PCL molecular chains during 
the electrospinning process also affects PCL crystallization. As the MNA content exceeds 10%, the characteristic 
diffraction peaks of MNA located at 12.2° and 13.8° appear, demonstrating the aggregation of MNA. 
For bone/tissue regeneration, the porous membrane must be strong enough to withstand the forces during 
surgical operation and those exerted by physiological activities and/or by tissue growth [9]. The stress-strain curves 
in Fig. 2D show that the membranes are elastic, a property critical for GTR membranes. The tensile strengths of the 
membranes in the wet state are in the range of 3.8-8.6 MPa, which meet the clinical GTR requirements. With the 
increase of MNA content, the tensile strength first decreases, reaches a minimum at PGH10, which has the thinnest 
fibers, and then increases until PGH30. 
3.1.4. Apparent WCA of the membranes 
The hydrophilicity of biomaterials has great influence on the adhesion and proliferation of cells. The electrospun 
PGH-MNA membranes are all hydrophilic with contact angles of about 60o while PCL is moderately hydrophobic 
with a contact angle of 129.6o, as shown in Fig. 3. The incorporation of gelatin significantly increases the 
hydrophilicity of the membranes because of the amine and carboxyl functional groups in the gelatin structure. 
Besides, with the increase of MNA content, the contact angle decreases because of the hydroxyl and polar 
imidazole ring functional groups on the MNA molecule. Such an improvement in hydrophilicity will increase tissue 
regeneration and the biodegradation rate of the membranes. 
3.1.5. Drug encapsulation efficiency and drug release profile of electrospun membranes 
The drug encapsulation efficiencies of PGH1, PGH5, PGH10, PGH20, PGH30, and PGH40 which are 93.6%, 
93.0%, 92.4%, 90.5%, 89.6%, and 87.1%, respectively, are higher than those of PG5, PG10, PG20, PG30, and 
PG40 which are 92.4%, 90.7%, 87.5%, 84.9, and 84.1%, respectively, because the better miscibility of PCL and 
gelatin results in better interaction of MNA with the polymer matrix and better dispersion of MNA in the nanofibers. 
With the increase of drug loading, the drug encapsulation efficiency decreases, probably because of the loss of a 
small part of the aggregated drug, which cannot be encapsulated into the nanofibers. 
The drug release profiles of the PGH-MNA membranes are presented in Fig.4. About 40% of the MNA is 
released from the membranes within 1 day and 60% within 3 days, with an initial burst release. Then the MNA 
tends to release at a slower, linear rate until 3 weeks. The mechanism of drug release is based on drug diffusion and 
gelatin biodegradation. The MNA on the surface of the nanofibers burst releases to PBS. The interaction between 
MNA and the polymer matrix leads to a sustained release of MNA from the nanofibers after the burst release. The 
smaller the diameter of the fibers, the shorter the drug diffusion route and the faster the drug release. The 
biodegradation of gelatin is slowed by the entangled PCL chains. The crystallinity of PCL also affects the drug 
release profile. Under the effects of the above factors, the membranes show a controlled and sustained drug release.  
3.1.6. In vitro biodegradation of electrospun membranes 
A desirable feature of any implantable polymeric scaffold would be synchronization of polymer degradation with 
the replacement by natural tissue produced from cells [33]. The GTR membranes must function for at least 4–6 
weeks to allow successful regeneration of the periodontal system [34]. The mass loss curves of different 
electrospun membranes are shown in Fig. 5A. In the first week, the mass loss of P30 is mainly due to MNA release 
while the mass loss of PGH30 is much higher than that of P30 because of the degradation of gelatin. The 
PGH-MNA nanofiber membranes show an obvious mass loss in 2 weeks caused by both drug release and gelatin 
hydrolysis on the surface of the nanofibers, followed by a slow and linear degradation because of the slow 
hydrolysis of gelatin molecules inside the nanofibers and PCL molecules. The SEM micrographs of PGH30 15 days 
and 30 days after degradation show that the surface of the nanofibers becomes rough with a uniform degradation 
process. The degradation of gelatin molecular chains results in the increase of nanofibers surface roughness, 
therefore accelerating the infiltration of water into the nanofibers. Besides, the crystallinity of PCL decreases with 
the incorporation of HAc, so the degradation rates of the PGH-MNA membranes are accelerated. The uniform 
degradation process also indicates the entanglement of PCL and gelatin chains. After degradation for 3 months, 
55%-70% by mass of the PGH-MNA membranes have degraded. As indicated in Fig.5B, after degradation for 1 
month, the tensile strength of every membrane is sufficiently high to support the growth of new tissues.  
3.2. Barrier function, in vitro antibacterial activity, and biocompatibility  
3.2.1. Barrier function to fibroblast cells  
The barrier function of the PGH-MNA nanofiber membranes were tested in vitro by simulating penetration of 
fibroblast cells into the membranes. As shown in Fig. S5, no cell gets to the opposite side of the membranes 
because the pores formed in the membranes are much smaller than fibroblast cells. All membranes after 
degradation for 1 month can still prevent the ingrowth of cells (data not shown). 
3.2.2. In vitro antibacterial activity  
Bacterial inhibition experiments were used to determine the minimal inhibition content of MNA loaded in the 
membranes. The growth of Fusobacterium nucleatum can be visualized directly from the plate (Fig. 6) to assess the 
antibacterial activity. Bacterial inhibition zones are clearly observed around the membranes. The membranes with 
MNA content over 5% show a more obvious antibacterial activity than PGH1 and can maintain long term 
antibacterial eﬀects because of the slow but sustained release of MNA. Additionally, the membranes can inhibit 
bacterial growth in an area much larger than the membrane size because of the diffusion of MNA into the agar.  
3.2.3. Cytotoxicity of PGH-MNA nanofiber membranes 
According to the results of in vitro cytotoxicity (see S5), the PGH-MNA membranes show no cytotoxicity to 
L929 cells until the MNA content reaches 40%. Incubated in the extract substrates of the membranes, L929 cells 
show health growing morphologies. The membranes also show no cytotoxicity to hPDLFs and ROS cells. 
3.2.4. Proliferation of cells on PGH-MNA nanofiber membranes 
Attachment, adhesion, and spreading occur in the first phase of cell-material interactions and will influence the 
cell’s capacity to proliferate on the biomaterial and cell morphology. The viability of the cells proliferated on the 
membranes indicates the biocompatibility of the membranes. For all the tested membranes, with incubation, the 
number of cells increases continuously during the 7 days of culture, as shown in Fig. 7A, indicating that all the 
membranes are nontoxic and support cell proliferation. For PGH40, as the MNA released in the culture medium 
reaches a sufficiently high content, the cell growth is adversely affected. As shown in Fig. 7B, hPDLFs and ROS 
cells also proliferate well after incubation for 48 hours on the membranes, with no statistical difference between the 
cells proliferating on the membranes and those proliferating on TCP as blank control. Because the antibacterial 
activities of PGH30 and PGH40 are higher those of other membranes but PGH40 adversely affects cell 
proliferation, a MNA content of 30% is the highest drug content with the best antibacterial activity but without 
cytotoxicity. 
The morphology of L929 cells proliferating on PGH30 was observed by SEM and CLSM. Because the size of 
the cell is much larger than the pore size of membrane, the cells grow on the surface of the membrane without 
infiltrating in the thickness direction. As shown in both SEM and CLSM micrographs, after 3 days seeding, the 
L929 cells reach only approximately 30% confluency with most round shape. With proliferation, the number of 
cells increases significantly, forming almost a confluent layer with the characteristic spindle shape and stretching 
across the substrate on day 7. Cells demonstrate extension and spreading cytoskeleton from CLSM images. The 
specific structures—filopodia and lamellipodia—related to the cell motility of fibroblasts can be observed both 
from SEM and CLSM micrographs. The cells emit cytoplasmic process towards the fibers and neighboring cells, 
communicating with the surrounding micro-environment and neighboring cells and allowing the passage of 
messengers [35]. Thus, we can conclude that even with a high content of drug and the use of organic solvent during 
the electrospinning process, PGH30 has no negative effect on cell morphology, viability, and proliferation. 
3.3. In vivo biocompatibility and degradation of membranes 
3.3.1. Gross morphology 
From previous study, we have concluded that MNA-loaded PCL membrane is effective in reducing the 
inflammatory response after implantation (see S6). The effect of MNA content on the anti-inflammation ability and 
biocompatibility of the PGH-MNA nanofiber membranes was investigated. During the experiments, all the rabbits 
remained in good health with no wound complications. For all the membranes, no acute or chronic inflammation, 
necrosis, or adverse tissue reaction was identified. The membranes were absorbed completely after 6 months. 
3.3.2. Histology 
Host reactions following implantation of biomaterials include injury, blood-material interactions, provisional 
matrix formation, acute inflammation, chronic inflammation, granulation tissue development, foreign body reaction, 
and fibrous capsule development [36]. 
The 1 week post-operation is a high-incidence season of acute inflammatory response to biomaterials, which is 
marked by the presence of neutrophils. As shown in Fig. 8, at 1 week implantation, no neutrophils are observed 
around PGH5, PGH10, and PGH30, an indication of no obvious inflammatory response for these membranes. 
Fibroblasts infiltration on PGH10 and PGH30 are, on average, less than that on PGH5 at 1 week. At 3 weeks 
implantation, only a small amount of mononuclear cells were observed around the three membranes, showing no 
obvious chronic inflammation. Besides, the number of mononuclear cells around PGH5 is a little higher than that 
around PGH 10 and PGH30. No fibrous capsules form around the samples after 3 and 8 weeks implantation. At 8 
weeks implantation, all three membranes start to degrade and the nanofibers break, resulting in increases in pore 
size and porosity. The biodegradation rate of PGH10 is higher than those of PGH5 and PGH30 because of the 
thinner nanofibers of PGH10. At week 12, fibroblasts have infiltrated into PGH5 and PGH10, but not PGH30. The 
surrounding tissues of all three membranes show a normal wound healing process. At 16 weeks implantation, a 
mass of fibroblasts, monocytes and multinucleated giant cells, as well as blood vessels are observed inside of PGH5 
and PGH10. Most part of PGH5 and PGH10 are replaced by fibrous tissues. However, PGH30 still possess barrier 
function, and integration of PGH30 and fibrous tissue at the interface is achieved. At week 24, all three membranes 
are almost completely swallowed by macrophages. 
3.3.3. In vivo degradation 
In the design of GTR/GBR membrane, it is important to match the in vivo degradation rate of the membrane with 
the tissue regeneration rate [37]. The morphological changes of the nanofibers during in vivo degradation were 
evaluated by observing cross sections of the membranes by SEM (Fig. 9). After 16 weeks implantation, both PGH5 
and PGH10 have degraded with nanofibers breakages, but PGH30 still retains the unique nanofiber morphology 
with no obvious fragmentation. The incorporation of gelatin increases the biodegradation rate of the membranes 
compared with P0 and P30, as shown in Fig. S7. 
4. Discussion  
The aim of the current study was to fabricate electrospun membranes with drug release as anti-infective 
GTR/GBR membranes and to evaluate their effects on bacterial growth, biocompatibility, and biodegradability. We 
hypothesized that an electrospun membrane loaded with antibacterial drug would reduce bacterial colonization and 
hence prevent infection which is considered as the major reason for GTR/GBR failure in clinical applications. For 
this purpose, different contents of MNA were loaded in PCL/gelatin nanofibers by using electrospinning.  
To solve the immiscibility of natural gelatin and synthetic PCL, a tiny amount of HAc was introduced into the 
electrospinning system. The phase separation of PCL and gelatin was solved, and the PCL and gelatin 
macromolecular chains were dispersed homogeneously in the uniform PGH-MNA nanofibers. Thus, the 
preparation of uniform and scalable production of the electrospun membranes was guaranteed. After the 
introduction of HAc, chains entanglement and strong interaction between PCL, gelatin, and MNA were formed. 
The mechanical properties and drug encapsulation efficiencies of the membranes were improved. Drug was 
released in a more controlled and sustained profile. The contact angles of PGH-MNA membranes were higher than 
those of PG-MNA membranes at the same MNA content. Gelatin nanofibers dispersed in a PG-MNA membrane 
increase the surface roughness of the membrane and absorb water, resulting in a decrease of contact angle. But with 
PCL and gelatin homogeneously dispersed in the nanofibers of a PGH-MNA membrane, the contact angle of the 
membrane is affected by the hydrophobic PCL and hydrophilic gelatin. Our experimental results indicated that 
electrospun PGH-MNA nanofiber membranes had improved properties over those of PG-MNA membranes, with a 
combination of the favorable biological properties of gelatin and mechanical properties of PCL. Because the 
electrospun PCL/gelatin membranes and other similar gelatin-based natural-synthetic hybrid systems are widely 
used in scaffolds, this approach may be broadly applied to achieve homogeneous hybrid nanofibers with improved 
properties. 
Our main findings showed that PCL/gelatin electrospun nanofiber membranes acted as effective MNA carriers. 
The membranes showed appropriate mechanical properties and biodegradation rates. Cells could adhere and 
proliferate on the membranes without cytotoxicity until the MNA content reached 30%.The MNA released from 
the membranes effectively prevented the colonization of anaerobic bacteria. Electrospinning is an effective 
approach to functionalize PCL/gelatin membrane with MNA release. The membranes loaded with different contents 
of MNA showed a release profile independent of MNA content, including an approximately 60% release of MNA 
within 1 week, followed by a sustained release of up to 3 weeks. Such a release profile was predominantly 
controlled by diffusion and gelatin degradation. A large burst release is often regarded as a negative consequence 
for certain long term controlled release materials. However, in our case for anti-infective drug delivery, when a 
material is implanted into a tissue defect site, the first week is the high-incidence season of infection and 
inflammation. So a high initial release rate in the first few days after the implant is best for eliminating the 
intruding bacteria that are introduced during the implantation and systemically afterwards before they begin to 
proliferate. For the few bacteria that may survive the initial burst, a continued drug release is necessary to prevent 
their further population and inhibit the occurrence of latent infection [38]. So this 3-week prolonged drug release is 
considered to be an optimal treatment. Besides, the clinically recommended oral dosage of MNA for an adult 
patient is 0.4 g-0.8 g every time, which is much larger than the minimal inhibitory concentration value (0.2-2 mg/L) 
used to inhibit the growth of anaerobic bacterial. According to the density of the electrospun membranes (~0.36 
g/cm3) and the prototypical mediated dimension of a GTR membrane (5 cmx5 cmx250 μm), the total amount of 
MNA in PGH30 is about 0.047 g. The concentration of drug released at the tissue defect site in the first week is 
sufficiently high to inhibit the growth of bacteria, but much lower than the systemic treatment dosage. 
The in vivo experiments demonstrated that the organic solvent used in the electrospinning process had no adverse 
effect on the biocompatibility of the membranes. The membranes had good barrier function, as shown by the in 
vitro experiments, which could be used to effectively predict the in vivo barrier function of the membranes, so 
animal experiments could be avoided. PGH-MNA membranes were effective in reducing the inflammatory 
response after implantation, and all possessed good biocompatibility. The membranes showed different 
biodegradation rates with different MNA contents. Thus, we could choose the MNA content loaded in the 
nanofiber membranes depending on the level of infection and biodegradation time required of the regenerating 
tissue. 
5. Conclusions 
We developed an efficient, anti-infective GTR/GBR membrane made by metronidazole-loaded electrospun 
PCL/gelatin nanofibers. The phase separation of immiscible PCL and gelatin was mediated by introducing a tiny 
amount of HAc. A wide range of drugs (1-40 wt.%) were successfully incorporated into and released from the 
membranes. The MNA-loaded membranes can reduce inflammatory response upon implantation in rabbits by 
delivering MNA locally. PGH30 showed excellent comprehensive properties both in vitro and in vivo. Hence, 
PGH30 can be an optimal choice for localized drug delivery GTR/GBR membrane for the prevention of 
implant-associated infection. Besides, this drug delivery membrane can be used in various therapeutic applications 
in which controlled drug delivery is necessary, including pathologies demanding chronic drug treatments, wound 
healing, prevention of post-surgical adhesions and tissue engineering applications. 
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Fig. 1. SEM micrographs of electrospun nanofiber membranes with different contents of MNA.At low drug 
contents, the surface of the nanofibers is smooth. As the MNA content increases to 20%, a small amount of 
nanoparticles appear and are embedded on the surface of the nanofibers, demonstrating the formation of drug 
crystals. 
Fig. 2. Chemical, thermal, and mechanical properties of the electrospun membranes: (A) FTIR spectra, (B) DSC 
thermograms, (C) XRD patterns, and (D) stress-strain curves in the wet state. 
 
Fig. 3. (A) Water drop on the surface of the membranes and (B) the water contact angles of the membranes with 
different polymer matrix and MNA content. 
 
 Fig. 4. Cumulative drug release profiles of the electrospun membranes at different soaking times in PBS. 
 
Fig. 5. In vitro degradation of electrospun membranes: (A) mass loss during 3 months degradation, and (B) 
stress-strain curves and (C) SEM micrographs of PGH30 after degradation for 15 days and 30 days in PBS. 
 Fig. 6. Inhibition of bacterial growth on agar plates: (A) inhibition zone surrounding membranes with different 
contents of MNA after incubation for 1 day under anaerobic conditions at 37 oC; (b) inhibition zone diameter 
versus incubation time for membranes with different drug contents. 
 
Fig. 7. Viability of cells proliferated on the membranes: (A) optical density (O.D.) of L929 cells proliferated 1, 3, 5, 
and 7 days and (B) fluorescence intensities of hPDLFs and ROS cells cultured for 48 hours. SEM micrographs and 
confocal fluorescent images of L929 cells proliferated on PGH30 for (C)(D)(G)(H) 3days and (E)(F)(I)(J) 7 days. 
 
 
Fig. 8. Histological micrographs of PGH5, PGH10 and PGH30 with H&E staining (scale bar = 100 μm). 
 
Fig. 9. SEM micrographs of longitudinal sections of membranes at different time after subcutaneous implantation (scale 
bar = 5 μm). 
 
 
 
Table 1.Fiber diameter, pore size,and porosity of electrospun membranes with different contents of MNA 
Sample MNA 
(w/w%) 
Fiber diameter 
(μm) 
Pore size(μm) Apparent density 
(g/cm3) 
Porosity (%) 
PGH1 1 1.10±0.20 3.2±0.7 0.34 71.7 
PGH5 5 1.34±0.30 4.3±1.3 0.37 69.5 
PGH10 10 0.43±0.10 2.8±0.4 0.33 72.3 
PGH20 20 0.59±0.10 3.3±0.7 0.35 71.2 
PGH30 30 0.97±0.20 4.0±0.7 0.35 70.9 
PGH40 40 1.02±0.40 4.2±1.1 0.37 69.2 
 
 
 
